Nanjing King-Friend Biochemical Pharmaceutical (603707.SHG) Q2 2026 Earnings

30AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.05
0.11
0.18
0.24

Details

Expected EPS
0.08905325301
Actual EPS
0.049474029450000005
Surprise EPS
-0.04
Surprise Percent
+44.44%

Description

Nanjing King-Friend Biochemical Pharmaceutical (603707.SHG) has reported earnings of 0.049474029450000005 per share for Q2 2026.

0 Comments

Share your thoughts